February 26, 2015 — In the year 2000, the access to medicines movement opened the door to HIV/AIDS treatment for millions of people in the developing world by dramatically dropping the prices of antiretroviral drugs. But have government policies and international laws changed substantially in the wake of this movement? What are the most important developments in this area over the last 15 years? What has changed and what challenges remain? Finally, are there—or could there be—connections between the international movement for access to medicines, and emerging concerns about catastrophic drug prices in the U.S.? Amy Kapczynski, the co-founder of Universities Allied for Essential Medicines, addressed these and other questions in this USC Global Health Lecture Series event. This lecture was co-hosted by the USC Institute for Global Health, Program on Global Health & Human Rights and Center for Law and Social Science at the Gould School of Law.
Co-Founder & Advisory Board Member
Universities Allied for Essential Medicines
Amy Kapczynski is an associate professor of law at Yale Law School and director of the Global Health Justice Partnership. Her areas of research include information policy, intellectual property law, international law and global health. Prior to coming to Yale in 2012, she taught at the University of California, Berkeley, School of Law. She also served as a law clerk to Justices Sandra Day O’Connor and Stephen G. Breyer at the United States Supreme Court, and to Judge Guido Calabresi on the U.S. Court of Appeals for the Second Circuit. She received her A.B. from Princeton University, M. Phil. from Cambridge University, M.A. from Queen Mary and Westfield College at University of London, and J.D. from Yale Law School. She is also the co-founder of the Universities Allied for Essential Medicines.